N Engl J Med 377(13):12281239 Holst JJ, Deacon CF (1998) Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

and awake tracheal extubation." 2.5 Comparison with Other Guidelines: 2.5.1 ASA Guidelines: A multisociety consensus for the perioperative management of patients taking GLP1 RAs was developed by representatives from: The American Society of Anesthesiologists The American Gastroenterological Association The American Society for Metabolic and Bariatric Surgery The International Society of Perioperative Care of Patients with Obesity The Society of American Gastrointestinal and Endoscopic Surgeons Recommendation 1 [2] : Consider variables that increase the risk of delayed gastric emptying and aspiration with the periprocedural use of GLP-1RA: - The escalation phase of the medication- Higher doses- Weekly dosing- The presence of gastrointestinal symptoms (nausea, vomiting, abdominal pain, dyspepsia, and constipation) suggestive of delayed gastric emptying- Other medical conditions that may delay gastric emptying

Non-surgical approach: No incisions, no general anesthesia, and no extended recovery period
While this typically means morning administration for many patients, the critical factor is taking it before the first intake of the day, which may be at different times for shift workers
Online pharmacies deliver medications directly to patients homes, often without an in-person doctors visit